Skip to main content
CLRB
NASDAQ Life Sciences

Cellectar Posts 46c Per-Share Q3 Loss as Cash Runway Tightens

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.3
Mkt Cap
$12.099M
52W Low
$1.11
52W High
$4.7
52W Position info
17% above low
Off High info
72% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

CLRB sits 17% above its 52-week low of $1.11.

Summary

Cellectar reported a third-quarter loss of 46 cents per share, with the net loss widening to $8.0 million from $6.9 million in Q2. Nine-month cash burn reached $20.3 million, leaving roughly $21 million of liquidity that funds operations only into Q2 2027 without new financing. For a company of this size, that runway gap is the whole story — another raise is the base case, and dilution risk is front and center. The operating narrative still rests on iopofosine I 131, where the September CLOVER WaM subset data in Waldenström's macroglobulinemia was the last positive update, and the company is targeting an FDA filing in 1H 2027.

At the time of this announcement, CLRB was trading at $1.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.1M. The 52-week trading range was $1.11 to $4.70. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

CLRB - Latest Insights

CLRB
Nov 10, 2026, 6:55 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.28
Real-time Price: $1.23 info
Change: -$0.0499 (-4%) info
Market Cap: $11.627M info
CLRB
Sep 29, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.80
Real-time Price: $1.23 info
Change: -$0.5694 (-32%) info
Market Cap: $11.627M info
CLRB
Aug 13, 2026, 7:25 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.60
Real-time Price: $1.23 info
Change: -$1.37 (-53%) info
Market Cap: $11.627M info
CLRB
Aug 13, 2026, 7:15 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.60
Real-time Price: $1.23 info
Change: -$1.37 (-53%) info
Market Cap: $11.627M info
CLRB
Aug 13, 2026, 7:00 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.60
Real-time Price: $1.23 info
Change: -$1.37 (-53%) info
Market Cap: $11.627M info